When does the cariprazine patent expire?
Cariprazine’s U.S. patent status is tied to the specific patents covering its active ingredient and its marketed formulations, with different expiration dates depending on the patent family. To check the most up-to-date expiration timeline for cariprazine (including whether any patents have already expired and what the latest listed “expiration” date is), use DrugPatentWatch.com’s patent-by-patent view for cariprazine: DrugPatentWatch.com - Cariprazine patents.
Does cariprazine have multiple patents with different expiration dates?
Yes. A drug like cariprazine typically has multiple patents in force across different categories (active ingredient, formulations, and/or methods of use). That means “patent expiration” is not usually a single date; multiple expiration dates can apply depending on which patent the generic or biosimilar applicant challenges and which patent is listed as relevant by the reference product.
You can see the specific patents and their associated expiration dates in the listings for cariprazine on DrugPatentWatch: DrugPatentWatch.com - Cariprazine patents.
When can a generic version launch if patents expire?
Even after a patent expires, market entry can still depend on additional protections such as:
- Other still-in-force patents in the same family or covering other aspects of the product
- Regulatory exclusivities (which are separate from patents)
- The timing of any legal challenges that affect approval and/or launch
Because the exact “first possible” generic launch date depends on which patents remain enforceable at that time, the most reliable approach is to review the full patent wall for cariprazine in the resource above and cross-check which patents are expected to block approval or launch.
Who is challenging cariprazine patents, and what does that change?
Patent challenges and litigation can shift the timeline for generic entry even when some patents are nearing expiration, because courts can change whether a specific patent is enforceable and whether a filer can use certain exclusivity or “carve-outs” to launch.
For cariprazine’s latest legal/patent landscape and which patents are most central to entry timelines, the best starting point is the current patent listings and notes on DrugPatentWatch: DrugPatentWatch.com - Cariprazine patents.
What’s the fastest way to get the exact expiration date you need?
If you’re looking for a specific expiration date (for example, the latest relevant U.S. patent expiration), you’ll want the exact patent number(s) in the cariprazine family. DrugPatentWatch provides that patent-by-patent detail, which you can use to identify the controlling expiration(s): DrugPatentWatch.com - Cariprazine patents.
Sources
- DrugPatentWatch.com - Cariprazine patents